The Regenerative Medicine Regulations Guide Every Practitioner Needs
FDA frameworks, 361 vs 351, exosome regulation, state scope of practice, documentation standards, enforcement patterns, and a clinic setup checklist. 12 sections. Yours free.
Get the free guide
Enter your email and we'll send the full guide instantly. No spam.
No spam, ever Unsubscribe anytime Educational use only
- 01 The FDA Framework: 351 vs 361
- 02 Exosomes: The Regulatory Reality
- 03 Investigational Pathways
- 04 State Scope of Practice
- 05 State-by-State Landscape
- 06 Documentation: The Compliance Stack
- 07 Marketing and Claims Discipline
- 08 OIG Seven Components
- 09 Malpractice Insurance
- 10 Enforcement Reality
- 11 Clinic Setup Checklist
- 12 Regulatory Disclaimer
What's inside the guide
FDA Framework Decoded
The four criteria for 361 vs 351, the same surgical procedure exception, and what happens when a product fails any criterion. Plain language, not legalese.
Exosome Regulation Reality
The 2019 FDA safety notification, what it means for clinical practice, and why "exosomes aren't regulated" is factually wrong.
State-by-State Landscape
FL, AZ, OK, WY, UT, GA, TN, NV -- the states with new laws, what each requires, and the national FSMB signal on where this is heading.
Documentation Stack
The six documents every compliant practice keeps: informed consent, treatment records, traceability, storage logs, adverse event reporting, deviation reports.
Enforcement Patterns
Real cases: FTC's $51M judgment against a Miami stem cell clinic, FDA warning letters, and the patterns regulators target first.
Clinic Setup Checklist
20+ items: entity, licensing, insurance, supplier vetting, HIPAA, OSHA, informed consent, traceability, compliance program, and more.